Federal Register: September 8, 2009 (Volume 74, Number 172)
DOCID: fr08se09-116 FR Doc E9-21531
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
NOTICE: NOTICES
DOCID: fr08se09-116
SUBJECT CATEGORY:
Manufacturer of Controlled Substances; Notice of Registration
DOCUMENT SUMMARY:
By Notice dated April 17, 2009, and published in the Federal
Register on April 29, 2009, (74 FR 19598), Siemens Healthcare
Diagnostics Inc., Attn: RA, 100 GBC Drive, Mail Stop 514, Newark,
Delaware 19702, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the
basic classes of controlled substances listed in schedules I and II:
Drug Schedule Tetrahydrocannabinols (7370)............... I
Ecgonine (9180)............................ II
Morphine (9300)............................ II
The company plans to produce the listed controlled substances in bulk to be used in the manufacture of reagents and drug calibrator/ controls which are DEA exempt products.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Siemens Healthcare Diagnostics Inc. to manufacture the listed basic
classes of controlled substances is consistent with the public interest
at this time. DEA has investigated Siemens Healthcare Diagnostics Inc.
to ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the
company's physical security systems, verification of the company's
compliance with State and local laws, and a review of the company's
background and history. Therefore, pursuant to 21 U.S.C. 823, and in
accordance with 21 CFR 1301.33, the above named company is granted
registration as a bulk manufacturer of the basic classes of controlled substances listed.
Dated: August 28, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E921531 Filed 9409; 8:45 am]
BILLING CODE 441009P
SUMMARY:
Manufacturer of Controlled Substances; Registrations
DOCUMENT BODY 2:
By Notice dated April 17, 2009, and published in the Federal
Register on April 29, 2009, (74 FR 19598), Siemens Healthcare
Diagnostics Inc., Attn: RA, 100 GBC Drive, Mail Stop 514, Newark,
Delaware 19702, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the
basic classes of controlled substances listed in schedules I and II:
Drug Schedule Tetrahydrocannabinols (7370)............... I
Ecgonine (9180)............................ II
Morphine (9300)............................ II
The company plans to produce the listed controlled substances in bulk to be used in the manufacture of reagents and drug calibrator/ controls which are DEA exempt products.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Siemens Healthcare Diagnostics Inc. to manufacture the listed basic
classes of controlled substances is consistent with the public interest
at this time. DEA has investigated Siemens Healthcare Diagnostics Inc.
to ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the
company's physical security systems, verification of the company's
compliance with State and local laws, and a review of the company's
background and history. Therefore, pursuant to 21 U.S.C. 823, and in
accordance with 21 CFR 1301.33, the above named company is granted
registration as a bulk manufacturer of the basic classes of controlled substances listed.
Dated: August 28, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E921531 Filed 9409; 8:45 am]
BILLING CODE 441009P